Catalent Appoints Ricardo Zayas As North American Biologics Operations Leader
January 18, 2023
January 18, 2023
SOMERSET, New Jersey, Jan. 18 -- Catalent Inc., a pharma, biotech and consumer health company, issued the following news on Jan. 17, 2023:
Catalent, Inc. (NYSE: CTLT), the leader in enabling the development and supply of better treatments for patients worldwide, today announced the appointment of Ricardo Zayas as Senior Vice President, Operations, Biologics North America. Mr. Zayas will be responsible for all of the company's North American biologics operations, including its center . . .
Catalent, Inc. (NYSE: CTLT), the leader in enabling the development and supply of better treatments for patients worldwide, today announced the appointment of Ricardo Zayas as Senior Vice President, Operations, Biologics North America. Mr. Zayas will be responsible for all of the company's North American biologics operations, including its center . . .